Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.61
Delayed Data
As of May 22
 +0.11 / +4.40%
Today’s Change
1.93
Today|||52-Week Range
7.85
-17.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization--1.0K----
 
 
 
Operating ExpensesGross Income0.00-1.0K0.000.00
 
 
General Expenses602.5K471.1K305.4K344.7K
 
 
 
 
 
Research And Development233.2K123.6K35.6K53.0K
 
 
 
 
 
Total Operating Expenses602.5K472.1K305.4K344.7K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-602.5K-472.1K-305.4K-344.7K
 
 
 
 
 
Extraordinary Charge0.000.000.00-847.3K
 
 
Other Expenses-2.0K-11.1K-1.0K-12.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-577.5K-483.2K-291.1K-1.2M
 
 
 
 
 
Net Income-577.5K-483.2K-291.1K-1.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.7M2.7M2.7M2.7M
 
 
 
 
 
Shares To Calculate EPS Diluted2.7M2.7M2.7M2.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.20-$0.20-$0.10--
 
 
 
 
EPS Diluted-$0.20-$0.20-$0.10-$0.40